...
首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.
【24h】

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

机译:根据Ki-67的表达,类固醇激素受体的状态和化疗疗程的数量来表示诺模图,以预测乳腺癌术前化疗后的病理学完全缓解。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Tools able to predict pathological complete response (pCR) to preoperative chemotherapy might improve treatment outcome. PATIENTS AND METHODS: Data from 783 patients with invasive ductal carcinoma treated with preoperative chemotherapy and operated at the European Institute of Oncology were used to develop a nomogram using logistic regression model based on both categorical (clinical T and N, HER2eu, grade and primary therapy) and continuous variables (age, oestrogen receptor (ER), progesterone receptor (PgR), Ki-67 expression and number of chemotherapy courses). The performance of the resulting nomogram was internally evaluated through bootstrapping methods. Finally the model was externally validated on a patient set treated in other institutions and subsequently operated at the EIO. RESULTS: At multivariable analysis the probability of pCR was directly associated with Ki-67 expression (OR for 10% increase in the percentage of positive cells, 1.15, 95% confidence interval (CI), 1.03, 1.29) and number of chemotherapy courses (OR for one cycle increase, 1.31, 95% CI, 1.12, 1.53) and inversely associated with ER and PgR expression (ORs for 10% increase in the percentage of positive cells, 0.86, 95% CI 0.79, 0.93 and 0.82, 95% CI 0.69, 0.99, respectively). The nomogram for pCR based on these variables had good discrimination in training as well in validation set (AUC, 0.78 and 0.77). CONCLUSION: The use of a nomogram based on the number of preoperative courses, degree of Ki-67 and steroid hormone receptors expression may be useful for predicting the probability of pCR and for the design of the proper therapeutic algorithm in locally advanced breast cancer.
机译:背景:能够预测术前化疗病理完全缓解(pCR)的工具可能会改善治疗效果。患者与方法:使用来自欧洲肿瘤研究所的783例术前化学疗法治疗的浸润性导管癌患者的数据,通过基于Logistic回归模型的分类(临床T和N,HER2 / neu,年级和初级治疗)和连续变量(年龄,雌激素受体(ER),孕激素受体(PgR),Ki-67表达和化疗疗程数)。通过引导方法在内部评估所得列线图的性能。最后,该模型在其他机构接受治疗并随后在EIO上运行的患者组上进行了外部验证。结果:在多变量分析中,pCR的可能性与Ki-67表达直接相关(OR为阳性细胞百分比增加10%,1.15、95%置信区间(CI),1.03、1.29)和化疗疗程数( OR为一个周期增加1.31、95%CI,1.12、1.53),并与ER和PgR表达呈负相关(OR为阳性细胞百分比增加10%,0.86、95%CI 0.79、0.93和0.82、95%) CI分别为0.69、0.99)。基于这些变量的pCR诺模图在训练以及验证集(AUC,0.78和0.77)方面都有很好的区分度。结论:使用基于术前病程数,Ki-67和类固醇激素受体表达量的列线图可能有助于预测pCR的可能性,并用于设计局部晚期乳腺癌的适当治疗算法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号